3-hydroxybenzylhydrazine has been researched along with Leukemia, Basophilic, Acute in 1 studies
3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, H | 1 |
| Iida, Y | 1 |
| Oguro, K | 1 |
| Kojima, M | 1 |
| Ichiyama, A | 1 |
1 other study available for 3-hydroxybenzylhydrazine and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Tryptophan hydroxylase activity in serotonin producing mast cells. Dependence on intracellular iron concentration manipulated by permeable chelators.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Bone Marrow Cells; Cells, Cultured; Culture M | 1996 |